Stocks
Quest Diagnostics Incorporated Financial Statements (DGX) |
||||||||||
| Quest Diagnostics Incorporatedsmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 22.02.2021 | 28.02.2022 | 31.12.2022 | 21.02.2023 | 22.02.2024 | 24.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 9 437 | 10 788 | 9 883 | 9 883 | 9 252 | 9 237 | |||
| Operating Income, bln rub | 1 971 | 2 381 | 1 428 | 1 428 | 1 351 | 1 239 | ||||
| EBITDA, bln rub | ? | 2 408 | 3 158 | 1 785 | 1 810 | 1 790 | 1 572 | |||
| Net profit, bln rub | ? | 1 431 | 1 995 | 946.0 | 946.0 | 854.0 | 803.0 | |||
| OCF, bln rub | ? | 2 005 | 2 233 | 1 718 | 1 718 | 1 272 | 888.0 | |||
| CAPEX, bln rub | ? | 418.0 | 403.0 | 404.0 | 404.0 | 408.0 | 281.0 | |||
| FCF, bln rub | ? | 1 587 | 1 830 | 1 314 | 1 314 | 864.0 | 607.0 | |||
| Dividend payout, bln rub | 297.0 | 309.0 | 305.0 | 305.0 | 314.0 | 239.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 20.8% | 15.5% | 32.2% | 32.2% | 36.8% | 29.8% | ||||
| OPEX, bln rub | 1 662 | 1 828 | 1 874 | 2 005 | 1 610 | 1 684 | ||||
| Cost of production, bln rub | 5 804 | 6 579 | 0.000 | 6 450 | 6 291 | 6 252 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 163.0 | 151.0 | 138.0 | 138.0 | 152.0 | 169.0 | ||||
| Assets, bln rub | 14 026 | 13 611 | 12 837 | 12 837 | 14 022 | 13 954 | ||||
| Net Assets, bln rub | ? | 6 759 | 6 444 | 5 893 | 5 893 | 6 307 | 6 432 | |||
| Debt, bln rub | 4 655 | 4 657 | 4 775 | 4 622 | 5 369 | 5 352 | ||||
| Cash, bln rub | 1 158 | 872.0 | 315.0 | 315.0 | 686.0 | 474.0 | ||||
| Net debt, bln rub | 3 497 | 3 785 | 4 460 | 4 307 | 4 683 | 4 878 | ||||
| Ordinary share price, rub | 119.2 | 173.0 | 156.4 | 156.4 | 137.9 | 131.3 | ||||
| Number of ordinary shares, mln | 134.0 | 125.0 | 116.0 | 116.0 | 112.0 | 111.0 | ||||
| Market cap, bln rub | 15 969 | 21 626 | 18 147 | 18 147 | 15 443 | 14 578 | ||||
| EV, bln rub | ? | 19 466 | 25 411 | 22 607 | 22 454 | 20 126 | 19 456 | |||
| Book value, bln rub | -1 281 | -1 818 | -2 419 | -2 419 | -2 592 | -2 590 | ||||
| EPS, rub | ? | 10.7 | 16.0 | 8.16 | 8.16 | 7.63 | 7.23 | |||
| FCF/share, rub | 11.8 | 14.6 | 11.3 | 11.3 | 7.71 | 5.47 | ||||
| BV/share, rub | -9.56 | -14.5 | -20.9 | -20.9 | -23.1 | -23.3 | ||||
| EBITDA margin, % | ? | 25.5% | 29.3% | 18.1% | 18.3% | 19.3% | 17.0% | |||
| Net margin, % | ? | 15.2% | 18.5% | 9.57% | 9.57% | 9.23% | 8.69% | |||
| FCF yield, % | ? | 9.94% | 8.46% | 7.24% | 7.24% | 5.59% | 4.16% | |||
| ROE, % | ? | 21.2% | 31.0% | 16.1% | 16.1% | 13.5% | 12.5% | |||
| ROA, % | ? | 10.2% | 14.7% | 7.37% | 7.37% | 6.09% | 5.75% | |||
| P/E | ? | 11.2 | 10.8 | 19.2 | 19.2 | 18.1 | 18.2 | |||
| P/FCF | 10.1 | 11.8 | 13.8 | 13.8 | 17.9 | 24.0 | ||||
| P/S | ? | 1.69 | 2.00 | 1.84 | 1.84 | 1.67 | 1.58 | |||
| P/BV | ? | -12.5 | -11.9 | -7.50 | -7.50 | -5.96 | -5.63 | |||
| EV/EBITDA | ? | 8.08 | 8.05 | 12.7 | 12.4 | 11.2 | 12.4 | |||
| Debt/EBITDA | 1.45 | 1.20 | 2.50 | 2.38 | 2.62 | 3.10 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 4.43% | 3.74% | 4.09% | 4.09% | 4.41% | 3.04% | ||||
| Quest Diagnostics Incorporated shareholders | ||||||||||
